Hanna Svanback, our Head of Neuroscience for Northern Europe, recently spoke at the New Statesman’s Future of Healthcare Conference on tackling the health challenges that come with an ageing population. She was joined by representatives from government, parliament, and the third sector. It was great to hear the debate focus in on how we can all work together to detect, diagnose, and manage dementia and Alzheimer’s disease more effectively. Hanna shared “We are calling for the NHS, government, and industry to work in partnership to implement a pathway for Alzheimer’s disease that gives people access to a timely and accurate diagnosis, and the right care and support.” At Lilly, we have invested in research and development in this field for over three decades and are deeply committed to our partnerships to rethink what is possible in Alzheimer’s disease and ultimately pave the way for a better future for patients. #WeAreLillyUKandIreland
Hamna miss working with you !
Great to see your continued leadership Hanna!
EVP, Global Product Strategy and International Operations at LEO Pharma
4moHanna…so great to see you thriving! Continue to lead strong!